Related Experiment Video
Updated: Jun 6, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
[Liver fibrosis in hepatitis B: a dynamic process]
1Service d'Anatomie pathologique, Hôpital Beaujon, Clichy, France. pierre.bedossa@inserm.fr
Gastroenterologie Clinique Et Biologique
|November 25, 2010
Summary
Chronic hepatitis B can cause liver fibrosis, potentially leading to cirrhosis. Early-stage fibrosis is more reversible, and treatment is most effective after eradicating the hepatitis B virus.
Area of Science:
- Hepatology
- Virology
- Pathology
Context:
- Chronic hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide.
- Liver fibrosis, characterized by scar tissue accumulation, progresses to cirrhosis, increasing morbidity and mortality.
- Hepatic stellate cell activation is a key driver of liver fibrogenesis.
Purpose:
- To explore the mechanisms of liver fibrosis in chronic hepatitis B.
- To understand the dynamics of fibrosis progression and regression.
- To identify potential therapeutic strategies for anti-fibrotic treatment.
Summary:
- Liver fibrosis results from chronic hepatitis B, leading to tissue destruction and cirrhosis.
- Hepatic stellate cells play a crucial role in the fibrotic process.
- Experimental models aid in understanding fibrosis and developing new drugs.
- Hepatitis B virus eradication is essential for effective anti-fibrotic therapy.
- Early-stage fibrosis demonstrates greater potential for regression than advanced cirrhosis.
Impact:
- Improved understanding of liver fibrosis pathogenesis in chronic hepatitis B.
- Potential for developing novel anti-fibrotic therapies.
- Highlights the importance of viral eradication for treatment success.
- Informs clinical strategies for managing liver fibrosis and cirrhosis.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...